A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared with the Addition of Sitagliptin in Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Read time: 1 mins
Last updated:23rd May 2013
To assess the effect of treatment with MK-3102 compared with Sitagliptin on A1C. To assess the safety and tolerability of MK-3102.
|Study start date||2013-05-23|